Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Roche will invest more than $1 billion to obtain a 56%...
WuXi NextCODE Genomics, the newly formed...
WuXi PharmaTech, through its WuXi...
WuXi PharmaTech has borrowed $165...
Steve Yang, PhD, Executive Vice-President and COO of...
WuXi PharmaTech, a China-US CRO, will...
WuXi PharmaTech, China's largest...
WuXi PharmaTech sold a 5.55% stake in...
WuXi PharmaTech, the China-US CRO/CMO,...
WuXi PharmaTech, China's largest...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here